Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Radnet ( (RDNT) ) just unveiled an announcement.
On June 11, 2025, RadNet, Inc. announced that it secured a $100 million incremental term loan from Barclays Bank PLC, which will be used for future acquisitions and general corporate purposes. This financial move is part of an amendment to their existing credit agreement, with the new loan maturing on April 18, 2031. The loan enhances RadNet’s capacity to pursue strategic growth opportunities, supporting its national imaging center network and technology platforms. Additionally, at the 2025 Annual Meeting of Stockholders held on June 10, 2025, RadNet’s stockholders elected seven directors and approved the appointment of Ernst & Young LLP as the company’s independent registered public accounting firm for the year ending December 31, 2025.
The most recent analyst rating on (RDNT) stock is a Buy with a $65.00 price target. To see the full list of analyst forecasts on Radnet stock, see the RDNT Stock Forecast page.
Spark’s Take on RDNT Stock
According to Spark, TipRanks’ AI Analyst, RDNT is a Outperform.
RadNet’s strong financial performance, bolstered by robust revenue growth and operational efficiency, is a key strength. The recent merger announcement further boosts future growth prospects. However, profitability challenges and high leverage, along with valuation concerns due to a negative P/E ratio, temper the overall assessment.
To see Spark’s full report on RDNT stock, click here.
More about Radnet
RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States. The company operates a network of 401 outpatient imaging centers across several states, including Arizona, California, and New York. RadNet also offers radiology information technology and artificial intelligence solutions under the DeepHealth brand, along with teleradiology professional services.
Average Trading Volume: 798,339
Technical Sentiment Signal: Buy
Current Market Cap: $4.45B
See more data about RDNT stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue